MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 2,850.00
+65.00 (2.33%)
Sep 1, 2026, 3:30 PM KST
MedPacto Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,995 | 3,898 | - | - | - | - | |
Revenue Growth | 293.41% | - | - | - | - | - |
Cost of Revenue | 4,578 | 3,513 | - | - | - | - |
Gross Profit | 416.8 | 385.16 | - | - | - | - |
Selling, General & Admin | 4,064 | 4,052 | 3,613 | 4,427 | 5,021 | 4,607 |
Research & Development | 11,587 | 10,138 | 18,018 | 24,164 | 31,919 | 24,551 |
Amortization of Goodwill & Intangibles | 76.89 | 67.21 | 50.78 | 49.36 | 44.08 | 31.76 |
Other Operating Expenses | - | - | - | - | - | 12.46 |
Operating Expenses | 15,845 | 14,429 | 21,807 | 28,752 | 37,246 | 29,459 |
Operating Income | -15,428 | -14,044 | -21,807 | -28,752 | -37,246 | -29,459 |
Interest Expense | -127.05 | -117.31 | -91.94 | -493.23 | -9,621 | -7,769 |
Interest & Investment Income | 885.36 | 1,239 | 1,687 | 388.46 | 1,324 | 663.52 |
Earnings From Equity Investments | 234.65 | - | - | -390.44 | - | - |
Currency Exchange Gain (Loss) | -7.14 | -17 | -116.09 | 114.09 | 25.05 | -19.66 |
Other Non Operating Income (Expenses) | 86.33 | 199.32 | 85.4 | 64.07 | 9,272 | 19,278 |
EBT Excluding Unusual Items | -14,356 | -12,740 | -20,243 | -29,069 | -36,246 | -17,306 |
Gain (Loss) on Sale of Investments | 216.33 | -47.37 | 102.2 | 350.51 | 492.28 | 266.33 |
Gain (Loss) on Sale of Assets | 0.1 | -23.57 | - | -5.93 | - | - |
Other Unusual Items | - | - | - | -6,600 | - | - |
Pretax Income | -14,139 | -12,811 | -20,140 | -35,325 | -35,753 | -17,040 |
Net Income | -14,139 | -12,811 | -20,140 | -35,325 | -35,753 | -17,040 |
Net Income to Common | -14,139 | -12,811 | -20,140 | -35,325 | -35,753 | -17,040 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 34 | 34 | 34 | 21 | 33 | 20 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 21 | 33 | 20 |
Shares Change | 0.62% | 1.77% | 58.73% | -36.20% | 62.45% | 0.88% |
EPS (Basic) | -412.80 | -373.76 | -598.00 | -1664.87 | -1075.00 | -832.30 |
EPS (Diluted) | -412.80 | -373.76 | -598.00 | -1665.00 | -1075.00 | -832.30 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -12,278 | -13,481 | -16,873 | -26,402 | -30,491 | -25,909 |
Free Cash Flow Per Share | -358.47 | -393.32 | -500.99 | -1244.33 | -916.79 | -1265.52 |
Gross Margin | 8.34% | 9.88% | - | - | - | - |
Operating Margin | -308.89% | -360.24% | - | - | - | - |
Profit Margin | -283.09% | -328.61% | - | - | - | - |
Free Cash Flow Margin | -245.83% | -345.80% | - | - | - | - |
EBITDA | -14,347 | -12,888 | -20,265 | -26,919 | -35,380 | -27,736 |
D&A For EBITDA | 1,081 | 1,156 | 1,542 | 1,833 | 1,866 | 1,723 |
EBIT | -15,428 | -14,044 | -21,807 | -28,752 | -37,246 | -29,459 |